You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urothelial carcinoma

Showing 26 - 50 of 8,174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Neoadjuvant Chemotherapy in Upper Tract Urothelial Carcinoma

Not yet recruiting
  • Upper Excretory Tract Tumors
  • Patients with Upper excretory tract tumors
  • (no location specified)
Jan 3, 2023

Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Bicalutamide 150 mg
  • Placebo
  • Québec, Canada
    CHU de Québec - Université Laval
Sep 6, 2023

Urothelial Carcinoma Trial in Beijing (18F-FDG)

Recruiting
  • Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 18, 2022

Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

Not yet recruiting
  • Urothelial Carcinoma
  • disitamab vedotin
  • +4 more
  • (no location specified)
Jun 9, 2023

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

    Active, not recruiting
    • Hydronephrosis
    • +18 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

    Recruiting
    • Urothelial Carcinoma
    • Non-Invasive Bladder Urothelial Carcinoma
    • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 2, 2023

    Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

    Not yet recruiting
    • Urinary Bladder Neoplasms
      • (no location specified)
      Feb 14, 2023

      Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

      Recruiting
      • Urothelial Cancer
      • +3 more
      • Sacituzumab Govitecan (SG)
      • Enfortumab vedotin-ejfv (EV)
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Sep 28, 2022

      Urothelial Carcinoma Trial in Sohag (Expression of Cortactin anti body)

      Completed
      • Urothelial Carcinoma
      • Expression of Cortactin anti body
      • Sohag, Egypt
        Maisa Hashem Mohammed
      Jul 13, 2022

      Urothelial Carcinoma Trial (Avelumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • (no location specified)
      Oct 26, 2022

      CXCL5 asValuable Prognostic Marker in Urinary Bladder Urothelial

      Recruiting
      • Urinary Bladder Urothelial Carcinoma
        • Sohag, Egypt
          Faculty of Medicine, Sohag University
        Jul 26, 2022

        Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

        Not yet recruiting
        • Urothelial Carcinoma
        • Metastatic Cancer
        • Houston, Texas
          MD Anderson Cancer Center
        Nov 28, 2022

        Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

        Recruiting
        • Advanced Urothelial Carcinoma
        • +3 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Jun 28, 2022

        Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

        Active, not recruiting
        • Bladder Urothelial Carcinoma
        • Urothelial Carcinoma
        • Copper Cu 64 TP3805
        • +2 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Dec 13, 2022

        Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial

        Available
        • Urothelial Cancer of Renal Pelvis
        • +5 more
        • Mitomycin for pyelocalyceal solution
        • (no location specified)
        Aug 5, 2022

        Urothelial Carcinoma Trial in United States (Enfortumab Vedotin, Radical surgery)

        Not yet recruiting
        • Urothelial Carcinoma
        • Enfortumab Vedotin
        • Radical surgery
        • Basking Ridge, New Jersey
        • +6 more
        May 11, 2023

        Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

        Recruiting
        • Locally Advanced Bladder Urothelial Carcinoma
        • +13 more
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Jun 8, 2022

        Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

        Not yet recruiting
        • Advanced Urothelial Carcinoma
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Oct 9, 2023

        Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

        Recruiting
        • Urothelial Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Mar 8, 2023

        High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

        Not yet recruiting
        • High Grade Urothelial Carcinoma
        • +2 more
        • Washington, District of Columbia
        • +1 more
        Jan 5, 2023

        Bio Clinical Collection of Urothelial Carcinoma

        Recruiting
        • Urothelial Carcinoma
        • Bladder Cancer
        • collection of blood, urines, stool and tumor samples
        • Toulouse, France
          Rangueil University Hospital
        May 17, 2022

        Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

        Recruiting
        • Platinum-resistant Ovarian Cancer
        • +2 more
        • Mobile, Alabama
        • +7 more
        Jan 24, 2023